Sarasota, FL, Sept. 21, 2016 (GLOBE NEWSWIRE) -- Zion Research has published a new report titled “Cervical Cancer Diagnostic Test Market (Pap Smear Tests, Colposcopy, HPV Testing, Endocervical Curettage (ECC) and Others) for Hospitals, Laboratories and Other End-users - Global Industry Perspective, Comprehensive Analysis, Size, Share, Growth, Segment, Trends and Forecast, 2015 – 2021”. According to the report, the global cervical cancer diagnostic market accounted for USD 6.70 billion in 2015 and is expected to reach USD 9.46 by 2021, growing at a CAGR of around 5.9% between 2015 and 2021.
Cervical cancer is an abnormal growth of cervical cells in the cervix. Cervical cancer commonly spread through a virus termed as human papilloma virus (HPV). Most of the cervical cancer is caused due to HPV 16 and HPV 18 virus. The same viruses are also responsible for causing anal cancer and penile cancer in men. However, HPV 6 and HPV 11 are commonly associated with causing genital warts. With the growing number of cervical cancer diagnostic tests such as Pap smear tests, HPV testing and colposcopy for early detection, the demand of such market is described as highly competitive with high growth rate.
Browse 23 Market Tables and 32 Figures spread through 110 Pages and an in-depth TOC on “Global Cervical Cancer Diagnostic Test Market: By Test Type, Devices, Applications, End-user and Forecast 2015-2021”
Request free Sample Report @ https://www.zionmarketresearch.com/sample/soundbar-market
The global cervical cancer diagnostic test market was expected to witness the highest growth over the forecast period due to increasing percentage of HPV infected female population across the globe. According to the Centers for Disease Control and Prevention (CDC), six million people in the U.S. acquire HPV each year. At least 20 million already have it, and more than half of all sexually-active adults will be infected during their lifetime. Furthermore increasing the incidence of weakened immune system coupled with certain life history is also considered as a major governing factor which promotes the cause of cervical cancer in female and thus promotes the cervical cancer diagnostic market. Moreover, many lifestyle-related factors, such as having multiple sex partners, smoking, obesity, unsafe sex with inherited HPV-positive patient, are estimated to drive the cervical diagnostics market. However, lack of education regarding the prevalence of cervical cancer and the unwillingness of the female population to undergo cervical cancer prognosis would hinder the growth of the market. In addition, prevention of HPV done by HPV vaccination is can also act as restraining factor in a growth of cervical cancer diagnostic market.
Based on the test, the global market of cervical cancer diagnostic test is bifurcated into five types: Pap smear tests, colposcopy, HPV testing, endo-cervical curettage (ECC) and others (cone biopsy and loop electrosurgical excision procedure (LEEP). In terms of revenue, the Pap smear tests segment accounted for the largest share of approximately more than 50% of the total cervical cancer diagnostic tests market in 2015. This demand is expected to continue within the forecast period. Factors attributed to this growth is dominated by the economical price of Pap smear test. Similarly, the HPV testing market is forecast to grow at the fastest growth rate of approximately more than 9% from 2015 to 2021 of the cervical cancer diagnostic tests market.
Browse the full " Cervical Cancer Diagnostic Test Market (Pap Smear Tests, Colposcopy, HPV Testing, Endocervical Curettage (ECC) and Others) for Hospitals, Laboratories and Other End-users - Global Industry Perspective, Comprehensive Analysis, Size, Share, Growth, Segment, Trends and Forecast, 2015 – 2021 " report at https://www.zionmarketresearch.com/report/cer...est-market
Based on end-user, the global market of cervical cancer diagnostic test is bifurcated into three types: hospitals, laboratories, and others. In end-user segment, the hospital was the leading segment in 2015 and this segment is expected to continue its dominance during the forecast period due to the continuous rise in HPV virus across the globe.
In terms of geography, North America was the leading market for cervical cancer diagnostic test in 2015 in terms of revenue due to the availability of technologically advanced computer-guided screening tests. In addition increasing number of geriatric population in North America and Europe serves as a major driving factor for the growth of cervical cancer diagnostic test market in this region. Furthermore, lifestyle-related factor such as smoking, having multiple sex partners is very common in the U.S., and European countries. Moreover, cervical cancer diagnostic test has the huge opportunity in emerging market like Asia Pacific, Latin America due to the public awareness, increase disposable income, government initiatives, and healthcare infrastructure.
The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global cervical cancer diagnostic test market include Abbott Laboratories, Becton, Dickinson and Company, Femasys, Inc., Hologic, Inc., Guided Therapeutics, Inc., OncoHealth Corp., Quest Diagnostics, Inc., Roche Diagnostics, QIAGEN, and Zilico Ltd.
Inquire more about this report @ https://www.zionmarketresearch.com/inquiry/ce...est-market
This report segments the global cervical cancer diagnostic test market as follows:
Global Cervical Cancer Diagnostic Test Market: Test Analysis
- Pap Smear Tests
- Colposcopy
- HPV Testing
- Endocervical Curettage (ECC)
- Others {Cone Biopsy and Loop Electrosurgical Excision Procedure (LEEP)}
Global Cervical Cancer Diagnostic Test Market: End- User Analysis
- Hospitals
- Laboratories
- Others
Related Reports:
- Kidney Function Tests Market: https://www.zionmarketresearch.com/report/kid...sts-market
- Hospital Stretchers Market: https://www.zionmarketresearch.com/report/hos...ers-market
- Incubator Market: https://www.zionmarketresearch.com/report/incubator-market
- Urinalysis Market: https://www.zionmarketresearch.com/report/urinalysis-market
- Soft Tissue Repair Market: https://www.zionmarketresearch.com/report/sof...air-market
Global Cervical Cancer Diagnostic Test Market: Regional Segment Analysis
- North America
- US
- Europe
- UK
- Germany
- France
- Asia Pacific
- China
- Japan
- India
- Latin America
- Brazil
- Middle East And Africa
Purchase a direct copy of report with TOC @ https://www.zionmarketresearch.com/buynow/su/...est-market
About Us
Zion Market Research is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Zion Market Research experienced team of Analysts, Researchers, and Consultants uses proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Each Zion Market Research syndicated research report covers a different sector — such as pharmaceuticals, chemical, energy, food and beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, our syndicated reports strive to serve the overall research requirement of clients.
Follow Us LinkedIn: https://www.linkedin.com/company/zion-market-research
Follow Us Twitter: https://twitter.com/zion_research
Contact Us: Joel John 4283, Express Lane, Suite 634-143, Sarasota, Florida 34249, United States Tel: +49-322 210 92714 USA/Canada Toll Free No.1-855-465-4651 Email: sales@zionmarketresearch.com Website: https://www.zionmarketresearch.com/
